Vogel G
Sleep Laboratory, Emory University School of Medicine, Atlanta, GA 30306.
J Clin Psychiatry. 1992 Jun;53 Suppl:19-22.
The most common adverse effects associated with the use of benzodiazepine hypnotics are residual daytime effects (daytime sedation and daytime performance decrements), anterograde amnesia, and rebound insomnia. Studies show that these adverse effects are related to dose. Hence, benzodiazepine hypnotics should be used in low doses so as to minimize or prevent these common adverse effects. It is now generally accepted that benzodiazepines should not be administered long-term for the treatment of chronic "idiopathic" insomnia. Two noncontinuous sleep disturbances, insomnia in the elderly and transient insomnia in young and middle-aged adults, are probably the most acceptable indications for the use of benzodiazepines. Low doses of short- and intermediate-acting benzodiazepines (triazolam and temazepam) are efficacious in the treatment of insomnia in the elderly, and preliminary evidence suggests that they are efficacious in the treatment of transient insomnia in young and middle-aged adults.
使用苯二氮䓬类催眠药最常见的不良反应是日间残留效应(日间镇静和日间功能减退)、顺行性遗忘和反弹性失眠。研究表明,这些不良反应与剂量有关。因此,应使用低剂量的苯二氮䓬类催眠药,以尽量减少或预防这些常见的不良反应。目前普遍认为,苯二氮䓬类药物不应长期用于治疗慢性“特发性”失眠。两种非持续性睡眠障碍,即老年人失眠和中青年短暂性失眠,可能是使用苯二氮䓬类药物最可接受的适应症。低剂量的短效和中效苯二氮䓬类药物(三唑仑和替马西泮)对治疗老年人失眠有效,初步证据表明它们对治疗中青年短暂性失眠也有效。